Arundhati Parmar
Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts. Previously, she was Senior Editor at UBM's Medical Device + Diagnostic Industry. Arundhati has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again. Contact her at aparmar@medcitynews.com.
LinkedIn: https://www.linkedin.com/in/arundhati-parmar/
Twitter: @aparmarbb
-
Artificial Intelligence, BioPharma
Why Sofinnova is Betting on the Confluence of Digital Technology and the Life Sciences
Paris-based Sofinnova Partners announced last week that it has launched a new strategy aimed at investing in a new breed of startups that straddle the lines between data and biology.
-
MedCity Pivot: Blue Shield of California CEO Says Value of HealthTech Has Been Mixed So Far
Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company’s Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Health IT, Health Tech, Physicians, SYN
The Areas That Intermountain Health’s CIO Wants To Address With Technology (And the One He Doesn’t)
In an interview at the Vive conference in Nashville, Tennessee, Craig Richardville, Intermountain’s chief digital and information officer outlined the three areas of priority for Intermountain Health for which technology can be leveraged. But when it comes to a major headache for CIOs, Richardville seems to suggest that a government-led all-hands-on-deck approach is what is needed.
-
“Culling of the Herd”: How One CEO Believes SVB’s Failure May Accelerate M&A in Healthtech
Included Health CEO Owen Tripp believes that the sudden demise of Silicon Valley Bank may actually lead to a “culling of the herd” as healthtech companies yet to prove their value will stop functioning as standalone companies or get bought by larger companies with stable revenue and a proven business model.
-
Joint Commission CEO Wants to “Dispel the Myth” that Decarbonizing Healthcare Is Costly
Some actions to reduce healthcare’s carbon footprint actually will save money, said Jonathan Perlin, CEO of the nonprofit national and international accrediting organization.
-
Medcity Pivot Podcast: Chronic Disease Management With an Interventional Cardiologist
Steve Driver is an interventional cardiologist as well as medical director of digital therapeutics at Advocate Aurora Health, which last year merged with Atrium Health. In this episode, he talked about a pilot involving Omada Health targeting a prediabetes population, among other things.
-
Q&A: As Congressional Heat Builds on PBMs, What Is the Message From the Industry Lobby?
The largest six pharmacy benefit managers are being scrutinized by the Federal Trade Commission, while Congress is debating the Pharmacy Benefit Transparency Act. Meanwhile, states have their own ideas for reining in what they see as excesses of the industry. With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?
-
Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device
A new treatment under development by HeartPoint Global seeks to provide a minimally invasive and cheaper alternative to current treatments for pulmonary arterial hypertension.
-
MedCity Pivot Podcast Season 1 Launches With Focus on Chronic Disease Management
Season one focusing on chronic disease management kicks off with a conversation with Stephanie Tilenius, CEO of Vida Health that aims to treat both the mind and the body.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Consumer / Employer, Health Tech
With Livongo, did Zane Burke sell a lemon to Teladoc’s Jason Gorevic?
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
-
Consumer / Employer, Employee Benefits
Why Quantum Health’s CEO Believes He Has the Winning Formula for Healthcare Navigation
The healthcare navigation market — especially companies targeting self-insured employers — is fairly crowded. You […]
-
6 Takeaways From the 41st J.P. Morgan Healthcare Conference
The 41st annual J.P. Morgan Healthcare Conference concluded last week. After the pandemic prompted it to go virtual, it was back in person, smaller in size and more effective. Here are my takeaways.
-
Ending Involuntary Commitments Would Shift Burden of Montana’s Dementia Care to Strapped Communities
A budget estimate attached to proposed legislation in Montana raises questions about whether the state’s cash-strapped communities will have the capacity to care for patients with Alzheimer’s disease, other types of dementia or traumatic brain injuries by July 2025, when involuntary commitments would cease under the plan.
-
Devices & Diagnostics, BioPharma, Health Tech
Here are some interesting companies I met at JPM this week
Reporters are pitched endlessly about companies they need to meet at this annual healthcare conference and the ecosystem it has sprung. These companies stood out to me and they play in the biopharma, devices, diagnostics and health tech worlds.
-
Sanofi CEO: We Don’t Have a Leaky Bathtub
In a media briefing during the J.P. Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
